| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/14/2013 | US20130303586 Oligonucleotide compositions with enhanced efficiency |
| 11/14/2013 | US20130303531 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 11/14/2013 | US20130303518 Methods of Inhibiting the Catalytic Activity of a Protein Kinase and of Treating a Protein Kinase Related Disorder |
| 11/14/2013 | US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase |
| 11/14/2013 | US20130303482 Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors |
| 11/14/2013 | US20130303435 Smart Pro-Drugs of Serine Protease Inhibitors |
| 11/14/2013 | US20130302889 Differentiation of Bone Marrow Cells into Neuronal Cells and Uses Therefor |
| 11/14/2013 | US20130302448 Phytin aqueous solution and use of said solution for the preparation of a liquid nutritional supplement or a cosmetic composition |
| 11/14/2013 | US20130302340 Human timp-1 antibodies |
| 11/14/2013 | US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt |
| 11/14/2013 | DE112012000807T5 Pyrrolo[2,1-c][1,4]naphthodiazepin-verknüpfte Piperazinverbindungen und Verfahren zu deren Herstellung Pyrrolo [2,1-c] [1,4] naphthodiazepine-linked piperazine compounds and process for their preparation |
| 11/13/2013 | EP2662382A1 Sterol derivatives, method for preparing same, pharmaceutical compositions containing same and use thereof for the treatment of multiple glioblastomas |
| 11/13/2013 | EP2662380A1 Ibandronate polymorph A |
| 11/13/2013 | EP2662367A1 Novel indole or indazole derivative or salt thereof |
| 11/13/2013 | EP2662357A1 Novel bicyclic compound or salt thereof |
| 11/13/2013 | EP2662117A1 Herpes Simplex Virus for the treatment of liver cancer |
| 11/13/2013 | EP2662094A1 Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors |
| 11/13/2013 | EP2662090A1 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 11/13/2013 | EP2662082A1 Administration of mTOR inhibitors |
| 11/13/2013 | EP2662079A1 Uses of formulations of thyroid hormone antagonists and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells |
| 11/13/2013 | EP2661440A2 Methods for preparation of glycosphingolipids and uses thereof |
| 11/13/2013 | EP2661437A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS |
| 11/13/2013 | EP2661436A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 11/13/2013 | EP2661434A1 Novel ureas for the treatment and prevention of cancer |
| 11/13/2013 | EP2661282A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide |
| 11/13/2013 | EP2661274A1 Compositions and methods of aloe polysaccharides |
| 11/13/2013 | EP2661268A2 Inhibitors of polo-like kinase |
| 11/13/2013 | EP2661259A2 Acoustically responsive particles with decreased cavitation threshold |
| 11/13/2013 | CN103391939A Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes |
| 11/13/2013 | CN103391938A Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses |
| 11/13/2013 | CN103391936A Anticancer agent |
| 11/13/2013 | CN103391779A Prostate cancer therapy with HSP90 inhibitory compounds |
| 11/13/2013 | CN103391773A Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases |
| 11/13/2013 | CN103391772A Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases |
| 11/13/2013 | CN103387605A RTN4B polypeptide and monoclonal antibody thereof, hybridoma cell strain generating monoclonal antibody, and preparation and application of RTN4B polypeptide, monoclonal antibody and hybridoma cell strain |
| 11/13/2013 | CN103387603A Polypeptide related to RTN4B, and preparation and application thereof |
| 11/13/2013 | CN103387602A Novel open-chain tetrapeptide analogue and preparation method and use thereof |
| 11/13/2013 | CN103387601A Anti-dengue virus (DENV) heterocyclic peptide compounds and preparing methods and uses thereof |
| 11/13/2013 | CN103387596A Protopanaxadiol derivative and application thereof |
| 11/13/2013 | CN103387576A Aramide Raf kinase inhibitor based on purine structure and preparation method and application thereof |
| 11/13/2013 | CN103387569A Antineoplastic compounds, preparation method thereof and applications thereof |
| 11/13/2013 | CN103387568A Compounds, preparation method thereof and applications thereof |
| 11/13/2013 | CN103387567A NEPT compound and preparation method and application thereof |
| 11/13/2013 | CN103387550A Preparation method of antibacterial anti-cancer active compound |
| 11/13/2013 | CN103387536A Polymorphs of fluorine-containing deuterium-substituted omega-diphenylcarbamide or polymorphs of salts of fluorine-containing deuterium-substituted omega-diphenylcarbamide |
| 11/13/2013 | CN103387535A Substituted alkynylpyridine compound, and application method and use thereof |
| 11/13/2013 | CN103387277A Acidic electrolyzed water and composition thereof |
| 11/13/2013 | CN103387259A Method of producing iodine seed used for treating eye disease or cancer, and iodine seed prepared by using the same |
| 11/13/2013 | CN103386169A Ultrasonic tumor treatment device and treatment system |
| 11/13/2013 | CN103386136A Application of hydrophobic glucan in preparation of curcumin solubilizing agent and utilization method of hydrophobic glucan |
| 11/13/2013 | CN103386135A Preparation method of multifunctional medicine carrier integrating magnetism, fluorescence and thermosensitivity |
| 11/13/2013 | CN103386131A Pharmaceutical composition containing adenosine or derivative of adenosine |
| 11/13/2013 | CN103386123A Method and application of MEK used as costimulatory factor for preparing novel tumor vaccine |
| 11/13/2013 | CN103386120A Traditional Chinese medicine health product containing SOD |
| 11/13/2013 | CN103386119A Application of SIRT1 in adjusting rhythm and improving rhythm disorder |
| 11/13/2013 | CN103386109A Chinese medicine composition for treating lymph cancer |
| 11/13/2013 | CN103386091A Rupikang traditional Chinese medicine composition and capsule preparation method |
| 11/13/2013 | CN103386078A Application of traditional Chinese medicinal composition in preparation of medicines for treating colon cancer |
| 11/13/2013 | CN103386071A A Chinese herbal medicine combination for treating leukemia |
| 11/13/2013 | CN103386056A Anti-tumor traditional Chinese medicine troche and preparation method thereof |
| 11/13/2013 | CN103386046A Chinese medicine composition for treating esophagus cancer |
| 11/13/2013 | CN103386024A Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof |
| 11/13/2013 | CN103385989A Natural drug extract |
| 11/13/2013 | CN103385976A Applications of Pu'er tea or extracts thereof in anti-tumor |
| 11/13/2013 | CN103385973A Miao medicine for curing liver cancer and preparation method thereof |
| 11/13/2013 | CN103385953A A traditional Chinese medicine composition for the treatment of menopausal uterine fibroids and applications thereof |
| 11/13/2013 | CN103385943A Traditional Chinese medicine for treating cancer and preparation method thereof |
| 11/13/2013 | CN103385922A Natural pharmaceutical composition and preparation method |
| 11/13/2013 | CN103385917A Tianshan dracocephalum extract and application thereof |
| 11/13/2013 | CN103385913A Radix Astragali extract and its preparation method and preparation |
| 11/13/2013 | CN103385896A Preparation method of bacterial cellulose composite flavonoid compound |
| 11/13/2013 | CN103385877A Taxol and cimetidine pharmaceutical composition |
| 11/13/2013 | CN103385875A Nanometer chitosan artemisinin compound and preparation method thereof |
| 11/13/2013 | CN103385872A Pharmaceutical composition for treating liver cancer and preparation method thereof |
| 11/13/2013 | CN103385865A Application of 10-arylmethylideneanthrone compounds to preparing antitumor drugs |
| 11/13/2013 | CN103385858A Methylsulfonic acid imatinib granule and preparation method thereof |
| 11/13/2013 | CN103385856A Method for preparing nanometer particles of 5-ALA or 5-ALA derivatives |
| 11/13/2013 | CN103385851A Injectable medicine composition used for resisting cancer |
| 11/13/2013 | CN103385830A Traditional Chinese medicine composition and its preparation method and use |
| 11/13/2013 | CN102911877B Marine fungi cladosporium sphaerospermum and application thereof |
| 11/13/2013 | CN102746973B Formula and preparation method of health-preserving kidney-tonifying wine |
| 11/13/2013 | CN102743753B Preparation method of rare earth-modified oxygen-carrying carbon nanotube |
| 11/13/2013 | CN102649963B Human papillomavirus (HPV) L1-based recombinant adenovirus for preventing and treating esophagus cancer |
| 11/13/2013 | CN102641310B 一种鸦胆子油栓剂 One kind javanica oil suppositories |
| 11/13/2013 | CN102614197B Application of phenylacetyl fluorobenzene salicylamide compound in preparation of anti-cervical-cancer medicines |
| 11/13/2013 | CN102600437B Pharmaceutical composition for treating leiomyoma of uterus and application thereof |
| 11/13/2013 | CN102552371B Gynostemma pentaphylla extractive and application thereof to preparing medicine for treating tumor |
| 11/13/2013 | CN102526638B Chinese medicinal preparation for treating liver cancer |
| 11/13/2013 | CN102512627B Traditional Chinese medicine composition for postoperative lung cancer |
| 11/13/2013 | CN102481285B Use of derivatives of indoles for the treatment of cancer |
| 11/13/2013 | CN102475893B Method for treating human malignant solid tumor by using hepatocyte nuclear factor-1alpha |
| 11/13/2013 | CN102443044B N-substituted ester-containing phenyl-14 Beta-aminomethyl epitriptolide derivatives, preparation method and use thereof |
| 11/13/2013 | CN102443043B N-substituted-14 beta -(aminomethyl) triptodiolide derivative and preparation method and application thereof |
| 11/13/2013 | CN102443042B N-substituted methoxy-containing phenyl-14 Beta-aminomethyl epitriptolide derivatives, preparation method and use thereof |
| 11/13/2013 | CN102443041B N-substituted methyl phenyl-14 beta -(aminomethyl) triptodiolide derivative and preparation method and application thereof |
| 11/13/2013 | CN102443039B N-substituted amino phenyl-14 beta-(aminomethyl) triptodiolide derivative and preparation method and application thereof |
| 11/13/2013 | CN102432755B Multi-targeted photodynamic therapy polymer carrier and preparation method thereof |
| 11/13/2013 | CN102415995B Oversaturated self-microemulsified progesterone composition and preparation method of same |
| 11/13/2013 | CN102406921B Medical application of GHGKHKNK octopeptide with anti-tumor synergetic effect on 5-fluorouracil |
| 11/13/2013 | CN102397529B Compound propolis composition for treating chicken reticuloendotheliosis and preparation method thereof |